Literature DB >> 12462430

New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections.

G Donelli1, I Francolini, A Piozzi, R Di Rosa, W Marconi.   

Abstract

Intravascular catheters are widely employed in medical practice. However, complications such as local or systemic infections are frequently related to their use. The significant increase in this type of nosocomial infection has prompted the search for new strategies to prevent them. This paper reports on an experimental model to prevent catheter-related infections based on the adsorption of a beta-lactam antibiotic (cefamandole nafate) on functionalized urethane polymers. The polyurethanes synthesized were used to coat a commercial central venous catheter. The influence of functional groups on the polymer-antibiotic interaction was analyzed and the kinetics of the antibiotic release from the catheters was dynamically studied. We were able to realize a polymer-antibiotic system able to inhibit bacterial growth up to 7 days. These promising results have encouraged us to extend this experimental model to other polymer-antibiotic systems in order to identify those allowing bacterial growth inhibition for longer times.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462430     DOI: 10.1179/joc.2002.14.5.501

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  10 in total

Review 1.  Infections associated with medical devices: pathogenesis, management and prophylaxis.

Authors:  Christof von Eiff; Bernd Jansen; Wolfgang Kohnen; Karsten Becker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms.

Authors:  Jyotsna Chandra; Jasmine D Patel; Jian Li; Guangyin Zhou; Pranab K Mukherjee; Thomas S McCormick; James M Anderson; Mahmoud A Ghannoum
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

3.  Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces.

Authors:  I Francolini; P Norris; A Piozzi; G Donelli; P Stoodley
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Wild mushroom extracts as inhibitors of bacterial biofilm formation.

Authors:  Maria José Alves; Isabel C F R Ferreira; Inês Lourenço; Eduardo Costa; Anabela Martins; Manuela Pintado
Journal:  Pathogens       Date:  2014-08-06

Review 5.  Current Trends in Development of Liposomes for Targeting Bacterial Biofilms.

Authors:  Zora Rukavina; Željka Vanić
Journal:  Pharmaceutics       Date:  2016-05-24       Impact factor: 6.321

Review 6.  Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.

Authors:  Ranita Roy; Monalisa Tiwari; Gianfranco Donelli; Vishvanath Tiwari
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

Review 7.  An Overview of Biofilm Formation-Combating Strategies and Mechanisms of Action of Antibiofilm Agents.

Authors:  Syeda Tasmia Asma; Kálmán Imre; Adriana Morar; Viorel Herman; Ulas Acaroz; Hamid Mukhtar; Damla Arslan-Acaroz; Syed Rizwan Ali Shah; Robin Gerlach
Journal:  Life (Basel)       Date:  2022-07-23

Review 8.  Clinical review: new technologies for prevention of intravascular catheter-related infections.

Authors:  Stefania Cicalini; Fabrizio Palmieri; Nicola Petrosillo
Journal:  Crit Care       Date:  2003-09-29       Impact factor: 9.097

9.  Treatment of osteomyelitis defects by a vancomycin-loaded gelatin/β-tricalcium phosphate composite scaffold.

Authors:  J Zhou; X G Zhou; J W Wang; H Zhou; J Dong
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

Review 10.  Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria.

Authors:  Janaína Teixeira Costa de Pontes; Anna Beatriz Toledo Borges; Cesar Augusto Roque-Borda; Fernando Rogério Pavan
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.